Medicines and Healthcare products Regulatory Agency
| 1: Authorisation Number | UK MIA 21659 |
|---|---|
| 2: Name of authorisation holder | VALNEVA SCOTLAND LIMITED |
| 3: Address(es) of manufacturing site(s) |
VALNEVA SCOTLAND LIMITED, OAKBANK PARK ROAD, MID CALDER, LIVINGSTON, EH53 0TG, UNITED KINGDOM VALNEVA SCOTLAND LIMITED, 1 OAKBANK PARK PLACE, MID CALDER, LIVINGSTON, EH53 0TN, UNITED KINGDOM |
| 4: Legally registered address of authorisation holder | VALNEVA SCOTLAND LIMITED, OAKBANK PARK ROAD, MID CALDER, LIVINGSTON, EH53 0TG, UNITED KINGDOM |
| 5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 |
| 6: Legal Basis of authorisation | |
| 7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential |
| 8: Authorisation Date | 27/01/2025 |
| 9: Annexes attached | Annex 1 and/or Annex 2 |
SCOPE OF AUTHORISATION
Annex 1
Name and address of the site:
VALNEVA SCOTLAND LIMITED, OAKBANK PARK ROAD, MID CALDER, LIVINGSTON, EH53 0TG, UNITED KINGDOM
Human Medicinal Products
| Authorised Operations |
| MANUFACTURING OPERATIONS (according to part 1) |
| Part 1 - MANUFACTURING OPERATIONS |
| [ 1.1 ] Sterile Products |
| [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms) |
| [ 1.1.1.1 ] Large volume liquids |
| [ 1.3 ] Biological medicinal products |
| [ 1.3.1 ] Biological medicinal products |
| [ 1.3.1.2 ] Immunological products |
| [ 1.3.2 ] Batch certification |
| [ 1.3.2.2 ] Immunological products |
| [ 1.4 ] Other products or manufacturing activity |
| [ 1.4.2 ] Sterilisation of active substances/excipients/finished products: |
| [ 1.4.2.1 ] Filtration |
| [ 1.6 ] Quality control testing |
| [ 1.6.2 ] Microbiological: non-sterility |
| [ 1.6.3 ] Chemical/Physical |
| [ 1.6.4 ] Biological |
SCOPE OF AUTHORISATION
Annex 1
Name and address of the site:
VALNEVA SCOTLAND LIMITED, 1 OAKBANK PARK PLACE, MID CALDER, LIVINGSTON, EH53 0TN, UNITED KINGDOM
Human Medicinal Products
| Authorised Operations |
| MANUFACTURING OPERATIONS (according to part 1) |
| Part 1 - MANUFACTURING OPERATIONS |
| [ 1.1 ] Sterile Products |
| [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms) |
| [ 1.1.1.1 ] Large volume liquids Special Requirements Live Cells |
| [ 1.3 ] Biological medicinal products |
| [ 1.3.1 ] Biological medicinal products |
| [ 1.3.1.2 ] Immunological products Special Requirements Live Cells |
| [ 1.3.1.5 ] Biotechnology products |
| [ 1.3.2 ] Batch certification |
| [ 1.3.2.2 ] Immunological products Special Requirements Live Cells |
| [ 1.3.2.5 ] Biotechnology products |
| [ 1.4 ] Other products or manufacturing activity |
| [ 1.4.1 ] Manufacture of: |
| [ 1.4.1.3 ] Other Master Cell Bank and Working Cell Banks |
| [ 1.4.2 ] Sterilisation of active substances/excipients/finished products: |
| [ 1.4.2.1 ] Filtration |
| [ 1.6 ] Quality control testing |
| [ 1.6.2 ] Microbiological: non-sterility |
| [ 1.6.3 ] Chemical/Physical |
| [ 1.6.4 ] Biological |